| Financial Year |
March 31 2023 |
| Monetary Funds |
12,841,823,846.05 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,343,613,011.06 |
| Advances to Suppliers |
7,139,132.60 |
| Other Receivables |
75,587,155.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
720,000.00 |
| Dividend Receivable |
-- |
| Inventories |
1,616,536,674.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
394,387,502.03 |
| Total Current Assets |
17,023,795,948.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,126,515,623.22 |
| Investment Properties |
289,186.96 |
| Fixed Assetes |
5,847,750,720.13 |
| Under-construction Projects |
4,805,048,836.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,065,788,683.29 |
| R&D expenses |
4,218,469.07 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,346,536.83 |
| Deferred Income Tax Assets |
127,389,425.33 |
| Other Non-Current Assets |
1,459,694,864.16 |
| Sub-Total of Non-Current Assets |
14,502,705,576.55 |
| Total Assets |
31,526,501,525.07 |
| Short-Term Loans |
6,422,172,534.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
474,476,921.17 |
| Accounts Payable |
1,475,806,817.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
81,782,224.53 |
| Taxes Payable |
43,178,231.35 |
| Interest Payable |
2,586,332.55 |
| Dividend Payable |
-- |
| Other payables |
245,426,850.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,573,093,500.36 |
| Other Current Liabilities |
51,940,396.78 |
| Sub-Total of Current Liabilities |
11,785,162,890.39 |
| Long-term Loans |
5,918,973,845.30 |
| Bonds Payable |
2,741,997,413.52 |
| Long-Term Accounts Payable |
264,979,782.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
13,170,770.00 |
| Deferred Income Tax Liabilities |
30,686,751.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,133,862,569.24 |
| Total Liabilities |
20,919,025,459.63 |
| Paid-In Capital(Or Share Stock) |
1,044,175,874.00 |
| Capital Surplus |
2,702,810,521.82 |
| Surplus Reserve |
481,663,413.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,251,733,867.43 |
| Minority Stockholder's Interest |
2,889,547,053.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,717,929,011.47 |
| Owner's Equity（Stockholder's Equity） |
10,607,476,065.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,526,501,525.07 |
